What We Do

Tuberculosis

Strategy Leadership

Back

Gilla Kaplan

Director

Gilla Kaplan, director, Tuberculosis, leads the team that works to accelerate the reduction of TB incidence globally.

Willem Hanekom

Deputy Director

Willem Hanekom, deputy director, Tuberculosis, supports the discovery and development of new TB vaccines.

Katrine Thor Andersen

Deputy Director

Katrine Thor Andersen is responsible for strategy and business operations for the Tuberculosis and Global Health strategy, planning and management teams.

Daniel Chin

Deputy Director

Daniel Chin provides oversight for the foundation’s TB program in India, China, and South Africa, and leads the work with global partners and in product delivery.

David Hermann

Deputy Director

Dr. David Hermann, deputy director, is responsible for overseeing the TB Drugs portfolio and regimen development from discovery through product approval.

Visit Our Blog